<DOC>
	<DOCNO>NCT00372333</DOCNO>
	<brief_summary>The main aim study evaluate safety , efficacy , compliance , usage epicutaneously apply IDEA-033 joint / musculoskeletal pain soft tissue inflammation .</brief_summary>
	<brief_title>IDEA-033 Open Label Study</brief_title>
	<detailed_description>Multi-centre , one arm , multiple dose , open-label , home usage study . Adult volunteer experience joint pain , musculoskeletal pain , stiffness , soft tissue inflammation screen study participation .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Musculoskeletal Pain</mesh_term>
	<mesh_term>Arthralgia</mesh_term>
	<criteria>least 18 year old agree refrain chronic usage NSAIDs analgesic antiinflammatory drug provide course study document sporadic concomitant analgesic joint pain , musculoskeletal pain , stiffness , soft tissue inflammation designate target area ( ) appropriate selftreatment topical analgesic availability second person guarantee case selftreatment possible healthy skin target area ( ) know hypersensitivity IDEA033 NSAIDs history coagulation disorder history peptic ulcer gastric intolerance NSAIDs urinary tract infection clinically significant renal , hepatic , gastric disease acute chronic coexisting illness qualify exclusion accord clinical judgement investigator clinical laboratory value outside normal range deem clinically significant investigator Narcoticscontaining product within 7 day administer IMP Malignancy within past 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>musculoskeletal pain ; soft tissue inflammation ; IDEA-033</keyword>
</DOC>